Genetic and Epigenetic Characteristics and Latest Therapies for Melanomas
Source: Dermatology Advisor, July 2021
Melanoma, the most aggressive cutaneous cancer, metastasizes at very early stages of tumor development. Advances in treatment have produced therapies that target specific melanoma-associated mutations, as well as immune checkpoint blockade (ICB) therapies that strengthen patients’ anti-tumor immune response.
